Home/Filings/4/0000875320-24-000174
4//SEC Filing

Atkinson Edward Morrow III 4

Accession 0000875320-24-000174

CIK 0000875320other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:09 PM ET

Size

6.1 KB

Accession

0000875320-24-000174

Insider Transaction Report

Form 4
Period: 2024-06-11
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
  • Tax Payment

    Common Stock

    2024-06-11$481.96/sh6,824$3,288,89523,260 total
  • Sale

    Common Stock

    2024-06-12$478.00/sh7,288$3,483,66415,972 total
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001914164

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:09 PM ET
Size
6.1 KB